A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...
In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results